Hidden costs of caregiving: new study tracks financial toxicity in cirrhosis families
NCT ID NCT07140120
First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times
Summary
This observational study looks at the financial and social challenges faced by informal caregivers of people with cirrhosis. Researchers will measure out-of-pocket costs, lost work time, and financial distress using surveys. The goal is to understand how these burdens affect caregivers' well-being and healthcare use, without testing any new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could highlight the financial and social challenges caregivers face, pointing toward better support programs for families managing cirrhosis.
- What could go wrong
- This is a small, observational study (52 participants) that only measures outcomes without testing any treatment. Results may not apply to all caregivers or regions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor Scott & White Research Institute (BSW)
Dallas, Texas, 75246, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can extra doses of an old drug reverse liver scarring?
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?
- Could a dissolvable sponge replace medical glue for dangerous stomach vein bleeds?
- Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
- Zambia study tracks hepatitis b outcomes in hundreds of patients
- Unapproved device tested in early trial